erythromycin has been researched along with Myocardial Infarction in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adebesin, AM; Falck, JR; Fischer, R; Konkel, A; Lossie, J; Paudyal, MP; Puli, N; Schunck, WH; Vijaykumar, J; Wesser, T; Westphal, C; Zhu, C | 1 |
| Ghosh, M; Graham, DJ; Izem, R; Kang, EM; Lee, JY; Major, JM; Mosholder, AD; Zhou, EH | 1 |
| Gorelik, E; Masarwa, R; Matok, I; Muszkat, M; Perlman, A; Rotshild, V | 1 |
| IINO, S; TAKEUCHI, J | 1 |
| Awasthi, A; George, AK; Kunwar, AR | 1 |
| Grayston, JT; Heckbert, SR; Jackson, LA; Psaty, BM; Siscovick, DS; Smith, NL | 1 |
| Cooper, JW; Morton, MR | 1 |
1 review(s) available for erythromycin and Myocardial Infarction
| Article | Year |
|---|---|
Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Erythromycin; Macrolides; Myocardial Infarction; Network Meta-Analysis; Risk Factors | 2018 |
7 other study(ies) available for erythromycin and Myocardial Infarction
| Article | Year |
|---|---|
Development of Robust 17(
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arachidonic Acids; Dose-Response Relationship, Drug; Drug Stability; Epoxide Hydrolases; Esterification; Hepatocytes; Humans; Male; Mice; Microsomes, Liver; Myocardial Infarction; Myocytes, Cardiac; Rats, Sprague-Dawley; Rats, Wistar | 2019 |
Long-Term Risk of Acute Myocardial Infarction, Stroke, and Death With Outpatient Use of Clarithromycin: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Helicobacter Infections; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Proportional Hazards Models; Proton Pump Inhibitors; Retrospective Studies; Stroke; Time Factors; United Kingdom | 2018 |
NEW AND nonofficial remedies.
Topics: Anesthetics; Anesthetics, Local; Anti-Bacterial Agents; Antibiotics, Antitubercular; Convulsive Therapy; Erythromycin; Hexachlorophene; Humans; Myocardial Infarction; Scopolamine Derivatives; Sympathomimetics | 1955 |
[HEART VALVE DISEASES, MYOCARDIAL INFARCT AND CORONARY DISORDERS].
Topics: Antihypertensive Agents; Coronary Disease; Diet; Diet Therapy; Endocarditis; Endocarditis, Bacterial; Erythromycin; Heart Diseases; Heart Valve Diseases; Heart Valves; Humans; Myocardial Infarction; Penicillins; Physiology; Rheumatic Heart Disease; Syphilis; Syphilis, Cardiovascular | 1963 |
Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin.
Topics: Adolescent; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Drug Interactions; Electrocardiography; Erythromycin; Humans; Male; Methylphenidate; Myocardial Infarction | 2005 |
Past use of erythromycin, tetracycline, or doxycycline is not associated with risk of first myocardial infarction.
Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Chlamydia Infections; Chlamydophila pneumoniae; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Humans; Incidence; Male; Myocardial Infarction; Risk Factors; Tetracycline | 2000 |
Erythromycin-induced digoxin toxicity.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Digoxin; Erythromycin; Female; Humans; Myocardial Infarction | 1989 |